Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. With the fully automated coagulation analyzer the Ceveron® alpha and the semi-automated analyzers the Ceveron® one, four and ten the portfolio was completed. The Ceveron® alpha TGA offers the unique feature of a fully automated thrombin generation measurement in the routine: CV <5% and assay times <20min Peak Thrombin. Furthermore Technoclone provides a complete range for ADAMTS-13 testing, as well a complete portfolio for the new anticoagulants (DOAC´s) such as for Xa inhibitors and direct thrombin inhibitors.

Kawasumi Laboratories, Inc. engages in the manufacture and sale of medical devices and pharmaceuticals. It operates through the Hemodialysis and Plasmapheresis; and Blood Transfusion and Endovascular segments. The Hemodialysis and Plasmapheresis segment develops, produces, and sells dialyzers, blood tubing lines, arteriovenous fistula needles, and isotonic sodium chloride solutions. It also offers removal of pathogenic factors from blood by extracorporeal circulation. The Blood Transfusion and Endovascular segment offers infusion therapy products, blood bags, apheresis kits, and intravenous sets. The company was founded by Takumi Kawano on December 1, 1954 and is headquartered in Tokyo, Japan.

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Shanghai Jiangxia Blood Technology engages in the scientific research and development of blood purification treatment technology.

Research Medical, Inc., a subsidiary of Baxter International, Inc., is an American company located in Midvale, UT, that provides special cannulae and cardioplegia products for open heart surgery. The firm was founded by Gary L. Crocker. Baxter International, Inc. acquired Research Medical, Inc. on March 17, 1997 for $236 million.

Berco SpA manufactures, designs and produces components and systems for earth moving and special crawler tracked machines. The company was founded in 1920 and is headquartered in Ferrara, Italy.

Sinopharm Guizhou Blood Products Co., Ltd. engages in the manufacture, sale, research and development of blood plasma-based biopharmaceutical products. Its products include human serum albumin, intravenous immunoglobulin, human immunoglobulin, hepatitis B immunoglobulin and tetanus human immunoglobulin. The company was founded on June 28, 2006 and is headquartered in Kaili, China.

Linyi Jiyu Protein Co., Ltd., established on 2018-06-06, Business scope includes licensed projects:feed production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Feed Raw Material Sales;Bio-feed R&D;Sales of agricultural and sideline products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

HemoCleanse, Inc. develops sorbent-based technologies to remove toxins from blood. It offers HemoCleanse-DT, a sorbent-based centrifuge-like device for liver dialysis and drug overdose detoxification applications; and HemoCleanse-PF, a sorbent-based centrifuge-like device for removing protein-bound toxins from plasma in applications, such as treatment of sepsis and autoimmuned diseases. The firm also provides AmSorb Ammonium sorbent for use in HemoCleanse; as an oral sorbent for urea control in the treatment of patients with renal insufficiency or end stage renal disease; and for ammonium removal in treatment of patients with chronic liver diseases. The company was founded by Stephen R. Ash and Robert B. Truitt in 1989 and is headquartered in Lafayette, IN.

Chongqing Yifu Scientific Instrument Co., Ltd., established on 2014-05-13, Business scope includes general items:Research,to develop,Sales:basic software,application,a,Instrumentation,computer,Office equipment and mechatronics products;Sales:Distribution switch control equipment,Lighting appliances and equipment,Electrical equipment,Electronic Component,household appliances,Wire and Cable,lighting fixtures,electronic product(Free of Hazardous Chemicals),Machinery Parts,electrical equipment;processing:Machinery Parts,Electronic Component,electronic product(Free of Hazardous Chemicals),electrical equipment;wholesale,retail:Equipment,Wujinjiaodian,detergent(Free of Hazardous Chemicals);Computer software technology promotion service;Instrument Manufacturing;Process cleaner,Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals),Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kuraray Co., Ltd. engages in the manufacture and sale of functional resins, chemicals, textiles, medical products, and synthetic fibers. It operates through the following segments: Vinyl Acetate, Isoprene, Functional Materials, Fibers and Textiles, Trading, and Others. The Vinyl Acetate segment domestically produces polyvinyl alcohol resin, optical PVA film, and EVAL gas barrier. The Isoprene segment manufactures isoprene, fine chemicals, genestar, septon, liquid rubber, kurarity acrylic thermoplastic elastomer, and others. The Functional Materials segment offers methacrylic resin, clarino, and dental materials in medical business. The Fibers and Textiles segment sells kuralon, polyester staple, kuraflex, hook and loop fasteners, and others. The Trading segment includes importing and exporting as well as the wholesaling of fibers and textiles such as polyester filament and chemicals. The Others segment deals with activated carbon, aqua, and engineering business. The company was founded on June 24, 1926 and is headquartered in Tokyo, Japan.

HemoLife Medical, Inc. provides health care services. The company is headquartered in Dana Point, CA.

Chengdu Rongsheng Pharmaceutical Co., Ltd. operates as a plasma-processing company in China. It produces plasma derivatives, such as albumin and intravenous immunoglobulin, and hepatitis B and tetanus immunoglobulins. The company was founded in 1997 and is based in Chengdu, China. Chengdu Rongsheng Pharmaceutical Co., Ltd. operates as a former subsidiary of Chengdu Institute Of Biological Products. As per the transaction announced on June 24, 2008, Chengdu Rongsheng Pharmaceutical Co., Ltd. operates as a subsidiary of Beijing Tiantan Biological Products Co., Ltd..

they are an innovative startup, recognised as such on regional and national level, founded by operators and managers with decades of experience in dialysis, intensive care, cardiology, and medical devices in general. they have strongly and physically set up in the incubator of the Biomedical District of Mirandola. This district has the knowledge, technologies, enterprises and production capacities that allow us to quickly and efficiently develop therapies and products giving new stimulus and creating new jobs.